Pancreatic cancer: moving forward, step by step

Affiliations

Comment

Hanno Riess. Lancet Gastroenterol Hepatol. 2017 May.

. 2017 May;2(5):315-316.

doi: 10.1016/S2468-1253(17)30055-9. Epub 2017 Feb 28.

¹ Department of Hematology and Oncology, University Hospital Charité, Berlin, D-10117, Germany. Electronic address: hanno.riess@charite.de.

No abstract available

Comment on

Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.
Bachet JB, Hammel P, Desramé J, Meurisse A, Chibaudel B, André T, Debourdeau P, Dauba J, Lecomte T, Seitz JF, Tournigand C, Aparicio T, Meyer VG, Taieb J, Volet J, Monier A, Bonnetain F, Louvet C. Bachet JB, et al. Lancet Gastroenterol Hepatol. 2017 May;2(5):337-346. doi: 10.1016/S2468-1253(17)30046-8. Epub 2017 Feb 28. Lancet Gastroenterol Hepatol. 2017. PMID: 28397697 Clinical Trial.